Torley Helen

CIK 00015281854 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001528185

Recent Transactions

50 trades

Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-12-09+165,522→ 165,522 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$68.51/sh−10,406→ 714,882 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$8.11/sh+16,569→ 725,288 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$69.44/sh−5,402→ 709,480 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$71.60/sh−261→ 708,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-12-01$70.36/sh−500→ 708,980 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-12-01$8.11/sh−16,569→ 0 total
Gift
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-26−25,000→ 708,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-11-12$8.11/sh−20,000→ 16,569 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-12$71.09/sh−6,784→ 734,217 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-12$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-12$71.67/sh−498→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-12$70.22/sh−12,718→ 741,001 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-11$68.80/sh−4,000→ 745,219 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-11$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-11$69.73/sh−11,500→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-11$67.89/sh−4,500→ 749,219 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-11-11$8.11/sh−20,000→ 36,569 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-11-10$8.11/sh−20,000→ 56,569 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-10$69.30/sh−100→ 733,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-10$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-11-10$68.71/sh−19,900→ 733,819 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-03$8.11/sh+20,000→ 753,719 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-10-03$8.11/sh−20,000→ 76,569 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-03$69.83/sh−2,334→ 737,150 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-03$71.67/sh−724→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-03$68.47/sh−14,235→ 739,484 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-03$70.58/sh−2,707→ 734,443 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-02$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-02$71.28/sh−10,200→ 736,919 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-02$70.51/sh−6,600→ 747,119 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-02$74.67/sh−100→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-02$72.06/sh−2,400→ 734,519 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-02$73.24/sh−700→ 733,819 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-10-02$8.11/sh−20,000→ 96,569 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-01$75.69/sh−8,295→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-01$75.11/sh−11,705→ 742,014 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-10-01$8.11/sh−20,000→ 116,569 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-10-01$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-04$75.22/sh−2,300→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-04$74.33/sh−7,800→ 736,019 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-04$73.54/sh−9,900→ 743,819 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-09-04$8.11/sh−20,000→ 136,569 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-04$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-03$74.63/sh−10,500→ 733,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-03$74.22/sh−9,500→ 744,219 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-09-03$8.11/sh−20,000→ 156,569 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-03$8.11/sh+20,000→ 753,719 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-02$73.70/sh−16,288→ 737,131 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-02$8.11/sh+20,000→ 753,719 total

Companies

Recent Filings

Address

C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov